Kangmei Pharmaceutical Co Ltd (600518) — Financial Flexibility Index
Kangmei Pharmaceutical Co Ltd (600518) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥268.53 Million (operating CF CN¥219.96 Million minus capex CN¥48.57 Million) represents 0% of total liabilities (CN¥6.46 Billion). Also explore net asset momentum of Kangmei Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kangmei Pharmaceutical Co Ltd Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for Kangmei Pharmaceutical Co Ltd across 26 annual periods. Check strategic asset allocation of Kangmei Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kangmei Pharmaceutical Co Ltd (1999–2024)
Year-by-year free cash flow to debt coverage for Kangmei Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Kangmei Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.06x | CN¥-365.92 Million | CN¥-427.63 Million | CN¥6.59 Billion | ▼ -83.6% |
| 2023 | -0.03x | CN¥-217.78 Million | CN¥-317.52 Million | CN¥7.20 Billion | ▲ +64.7% |
| 2022 | -0.09x | CN¥-701.84 Million | CN¥-749.96 Million | CN¥8.18 Billion | ▼ -235.3% |
| 2021 | 0.06x | CN¥385.83 Million | CN¥214.21 Million | CN¥6.09 Billion | ▲ +108.0% |
| 2020 | 0.03x | CN¥1.33 Billion | CN¥1.03 Billion | CN¥43.74 Billion | ▼ -60.1% |
| 2019 | 0.08x | CN¥3.36 Billion | CN¥2.88 Billion | CN¥43.94 Billion | ▼ -26.7% |
| 2018 | 0.10x | CN¥4.90 Billion | CN¥305.62 Million | CN¥47.03 Billion | ▲ +242.3% |
| 2017 | -0.07x | CN¥-2.69 Billion | CN¥-4.84 Billion | CN¥36.78 Billion | ▼ -158.7% |
| 2016 | 0.12x | CN¥3.17 Billion | CN¥1.60 Billion | CN¥25.44 Billion | ▲ +27.5% |
| 2015 | 0.10x | CN¥1.88 Billion | CN¥508.86 Million | CN¥19.27 Billion | ▼ -39.9% |
| 2014 | 0.16x | CN¥1.81 Billion | CN¥1.13 Billion | CN¥11.16 Billion | ▼ -30.1% |
| 2013 | 0.23x | CN¥2.38 Billion | CN¥1.67 Billion | CN¥10.22 Billion | ▼ -28.9% |
| 2012 | 0.33x | CN¥2.41 Billion | CN¥1.01 Billion | CN¥7.38 Billion | ▼ -32.3% |
| 2011 | 0.48x | CN¥2.90 Billion | CN¥574.96 Million | CN¥5.99 Billion | ▲ +10.4% |
| 2010 | 0.44x | CN¥1.44 Billion | CN¥669.19 Million | CN¥3.28 Billion | ▲ +0.9% |
| 2009 | 0.43x | CN¥843.72 Million | CN¥119.47 Million | CN¥1.95 Billion | ▼ -19.5% |
| 2008 | 0.54x | CN¥696.16 Million | CN¥3.02 Million | CN¥1.29 Billion | ▼ -3.1% |
| 2007 | 0.56x | CN¥490.78 Million | CN¥162.55 Million | CN¥882.71 Million | ▼ -11.6% |
| 2006 | 0.63x | CN¥481.77 Million | CN¥68.32 Million | CN¥766.30 Million | ▼ -12.5% |
| 2005 | 0.72x | CN¥155.53 Million | CN¥133.13 Million | CN¥216.45 Million | ▲ +7.5% |
| 2004 | 0.67x | CN¥228.72 Million | CN¥78.52 Million | CN¥342.09 Million | ▲ +38.4% |
| 2003 | 0.48x | CN¥126.65 Million | CN¥78.02 Million | CN¥262.25 Million | ▼ -55.0% |
| 2002 | 1.07x | CN¥255.88 Million | CN¥53.47 Million | CN¥238.35 Million | ▲ +23.8% |
| 2001 | 0.87x | CN¥132.23 Million | CN¥15.69 Million | CN¥152.51 Million | ▲ +852.1% |
| 2000 | 0.09x | CN¥11.59 Million | CN¥9.96 Million | CN¥127.27 Million | ▼ -75.6% |
| 1999 | 0.37x | CN¥43.21 Million | CN¥30.25 Million | CN¥115.77 Million | — |